glp 1 agents Frontiers The Impact and Safety of

Some Part D plans have already announced that they will begin covering Wegovy this year, although it is not yet clear how widespread coverage will be in 2024

When to reassess If GI symptoms worsen instead of improving over the first 2-3 weeks of a step, if dysesthesia appears suddenly, or if you cannot keep food down, pause and consult a qualified clinician

PubChem Reference: View compound profile on NIH PubChem Key Characteristics MOLECULAR PROFILE Formula: C 38 H 49 N 9 O 5 Weight: 711.86 g/mol CAS: 170851-70-4 Structure: Aib-His-D-2-Nal-D-Phe-Lys PHYSICAL PROPERTIES Form: White to off-white lyophilized powder Solubility: Readily dissolves in water Selectivity: High receptor selectivity Storage: Keep refrigerated 3646 F (28 C)

Hadwiger, G., Dour, S., Arur, S., Fox, P

neither component is approved by the FDA or EMA

Gerstenberg, M